 | • レポートコード：GIR-107A14372 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アンドロゲン性脱毛症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アンドロゲン性脱毛症治療薬の種類別市場規模（RK-023、レファグロ、RCH-01、SM-04554、HYG-440、その他）、用途別市場規模（クリニック、病院、家庭用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アンドロゲン性脱毛症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Allergan, Inc.、Histogen, Inc.、R-Tech Ueno, Ltd.、Hygeia Therapeutics, Inc.、SWITCH Biotech LLC、Polichem S.A.、Kasiak Research Pvt. Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：RK-023、レファグロ、RCH-01、SM-04554、HYG-440、その他 ・用途別分析2016年-2026年：クリニック、病院、家庭用 ・アンドロゲン性脱毛症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アンドロゲン性脱毛症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アンドロゲン性脱毛症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アンドロゲン性脱毛症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アンドロゲン性脱毛症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Androgenic Alopecia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Androgenic Alopecia Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Androgenic Alopecia Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Androgenic Alopecia Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
RK-023
Refagro
RCH-01
SM-04554
HYG-440
Others
Market segment by Application can be divided into
Clinic
Hospital
Home Use
The key market players for global Androgenic Alopecia Drug market are listed below:
Allergan, Inc.
Histogen, Inc.
R-Tech Ueno, Ltd.
Hygeia Therapeutics, Inc.
SWITCH Biotech LLC
Polichem S.A.
Kasiak Research Pvt. Ltd.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Androgenic Alopecia Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Androgenic Alopecia Drug, with price, sales, revenue and global market share of Androgenic Alopecia Drug from 2019 to 2021.
Chapter 3, the Androgenic Alopecia Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Androgenic Alopecia Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Androgenic Alopecia Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Androgenic Alopecia Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Androgenic Alopecia Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Androgenic Alopecia Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 RK-023
1.2.3 Refagro
1.2.4 RCH-01
1.2.5 SM-04554
1.2.6 HYG-440
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Androgenic Alopecia Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Use
1.4 Global Androgenic Alopecia Drug Market Size & Forecast
1.4.1 Global Androgenic Alopecia Drug Sales in Value (2016-2026))
1.4.2 Global Androgenic Alopecia Drug Sales in Volume (2016-2026)
1.4.3 Global Androgenic Alopecia Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Androgenic Alopecia Drug Production Capacity Analysis
1.5.1 Global Androgenic Alopecia Drug Total Production Capacity (2016-2026)
1.5.2 Global Androgenic Alopecia Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Androgenic Alopecia Drug Market Drivers
1.6.2 Androgenic Alopecia Drug Market Restraints
1.6.3 Androgenic Alopecia Drug Trends Analysis
2 Manufacturers Profiles
2.1 Allergan, Inc.
2.1.1 Allergan, Inc. Details
2.1.2 Allergan, Inc. Major Business
2.1.3 Allergan, Inc. Androgenic Alopecia Drug Product and Services
2.1.4 Allergan, Inc. Androgenic Alopecia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Histogen, Inc.
2.2.1 Histogen, Inc. Details
2.2.2 Histogen, Inc. Major Business
2.2.3 Histogen, Inc. Androgenic Alopecia Drug Product and Services
2.2.4 Histogen, Inc. Androgenic Alopecia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 R-Tech Ueno, Ltd.
2.3.1 R-Tech Ueno, Ltd. Details
2.3.2 R-Tech Ueno, Ltd. Major Business
2.3.3 R-Tech Ueno, Ltd. Androgenic Alopecia Drug Product and Services
2.3.4 R-Tech Ueno, Ltd. Androgenic Alopecia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Hygeia Therapeutics, Inc.
2.4.1 Hygeia Therapeutics, Inc. Details
2.4.2 Hygeia Therapeutics, Inc. Major Business
2.4.3 Hygeia Therapeutics, Inc. Androgenic Alopecia Drug Product and Services
2.4.4 Hygeia Therapeutics, Inc. Androgenic Alopecia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 SWITCH Biotech LLC
2.5.1 SWITCH Biotech LLC Details
2.5.2 SWITCH Biotech LLC Major Business
2.5.3 SWITCH Biotech LLC Androgenic Alopecia Drug Product and Services
2.5.4 SWITCH Biotech LLC Androgenic Alopecia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Polichem S.A.
2.6.1 Polichem S.A. Details
2.6.2 Polichem S.A. Major Business
2.6.3 Polichem S.A. Androgenic Alopecia Drug Product and Services
2.6.4 Polichem S.A. Androgenic Alopecia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Kasiak Research Pvt. Ltd.
2.7.1 Kasiak Research Pvt. Ltd. Details
2.7.2 Kasiak Research Pvt. Ltd. Major Business
2.7.3 Kasiak Research Pvt. Ltd. Androgenic Alopecia Drug Product and Services
2.7.4 Kasiak Research Pvt. Ltd. Androgenic Alopecia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Androgenic Alopecia Drug Sales by Manufacturer
3.1 Global Androgenic Alopecia Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Androgenic Alopecia Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Androgenic Alopecia Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Androgenic Alopecia Drug Manufacturer Market Share
3.4.2 Top 6 Androgenic Alopecia Drug Manufacturer Market Share
3.5 Global Androgenic Alopecia Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Androgenic Alopecia Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Androgenic Alopecia Drug Market Size by Region
4.1.1 Global Androgenic Alopecia Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Androgenic Alopecia Drug Revenue by Region (2016-2026)
4.2 North America Androgenic Alopecia Drug Revenue (2016-2026)
4.3 Europe Androgenic Alopecia Drug Revenue (2016-2026)
4.4 Asia-Pacific Androgenic Alopecia Drug Revenue (2016-2026)
4.5 South America Androgenic Alopecia Drug Revenue (2016-2026)
4.6 Middle East and Africa Androgenic Alopecia Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Androgenic Alopecia Drug Sales in Volume by Type (2016-2026)
5.2 Global Androgenic Alopecia Drug Revenue by Type (2016-2026)
5.3 Global Androgenic Alopecia Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Androgenic Alopecia Drug Sales in Volume by Application (2016-2026)
6.2 Global Androgenic Alopecia Drug Revenue by Application (2016-2026)
6.3 Global Androgenic Alopecia Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Androgenic Alopecia Drug Sales by Type (2016-2026)
7.2 North America Androgenic Alopecia Drug Sales by Application (2016-2026)
7.3 North America Androgenic Alopecia Drug Market Size by Country
7.3.1 North America Androgenic Alopecia Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Androgenic Alopecia Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Androgenic Alopecia Drug Sales by Type (2016-2026)
8.2 Europe Androgenic Alopecia Drug Sales by Application (2016-2026)
8.3 Europe Androgenic Alopecia Drug Market Size by Country
8.3.1 Europe Androgenic Alopecia Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Androgenic Alopecia Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Androgenic Alopecia Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Androgenic Alopecia Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Androgenic Alopecia Drug Market Size by Region
9.3.1 Asia-Pacific Androgenic Alopecia Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Androgenic Alopecia Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Androgenic Alopecia Drug Sales by Type (2016-2026)
10.2 South America Androgenic Alopecia Drug Sales by Application (2016-2026)
10.3 South America Androgenic Alopecia Drug Market Size by Country
10.3.1 South America Androgenic Alopecia Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Androgenic Alopecia Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Androgenic Alopecia Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Androgenic Alopecia Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Androgenic Alopecia Drug Market Size by Country
11.3.1 Middle East & Africa Androgenic Alopecia Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Androgenic Alopecia Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Androgenic Alopecia Drug Typical Distributors
12.3 Androgenic Alopecia Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Androgenic Alopecia Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Androgenic Alopecia Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Allergan, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Allergan, Inc. Major Business
Table 5. Allergan, Inc. Androgenic Alopecia Drug Product and Services
Table 6. Allergan, Inc. Androgenic Alopecia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Histogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Histogen, Inc. Major Business
Table 9. Histogen, Inc. Androgenic Alopecia Drug Product and Services
Table 10. Histogen, Inc. Androgenic Alopecia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. R-Tech Ueno, Ltd. Basic Information, Manufacturing Base and Competitors
Table 12. R-Tech Ueno, Ltd. Major Business
Table 13. R-Tech Ueno, Ltd. Androgenic Alopecia Drug Product and Services
Table 14. R-Tech Ueno, Ltd. Androgenic Alopecia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hygeia Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Hygeia Therapeutics, Inc. Major Business
Table 17. Hygeia Therapeutics, Inc. Androgenic Alopecia Drug Product and Services
Table 18. Hygeia Therapeutics, Inc. Androgenic Alopecia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. SWITCH Biotech LLC Basic Information, Manufacturing Base and Competitors
Table 20. SWITCH Biotech LLC Major Business
Table 21. SWITCH Biotech LLC Androgenic Alopecia Drug Product and Services
Table 22. SWITCH Biotech LLC Androgenic Alopecia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Polichem S.A. Basic Information, Manufacturing Base and Competitors
Table 24. Polichem S.A. Major Business
Table 25. Polichem S.A. Androgenic Alopecia Drug Product and Services
Table 26. Polichem S.A. Androgenic Alopecia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Kasiak Research Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Kasiak Research Pvt. Ltd. Major Business
Table 29. Kasiak Research Pvt. Ltd. Androgenic Alopecia Drug Product and Services
Table 30. Kasiak Research Pvt. Ltd. Androgenic Alopecia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Androgenic Alopecia Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 32. Global Androgenic Alopecia Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Androgenic Alopecia Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Androgenic Alopecia Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 35. Head Office and Androgenic Alopecia Drug Production Site of Key Manufacturer
Table 36. Androgenic Alopecia Drug New Entrant and Capacity Expansion Plans
Table 37. Androgenic Alopecia Drug Mergers & Acquisitions in the Past Five Years
Table 38. Global Androgenic Alopecia Drug Sales by Region (2016-2021e) & (K Pcs)
Table 39. Global Androgenic Alopecia Drug Sales by Region (2021-2026) & (K Pcs)
Table 40. Global Androgenic Alopecia Drug Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Androgenic Alopecia Drug Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Androgenic Alopecia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 43. Global Androgenic Alopecia Drug Sales by Type (2021-2026) & (K Pcs)
Table 44. Global Androgenic Alopecia Drug Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Androgenic Alopecia Drug Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Androgenic Alopecia Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 47. Global Androgenic Alopecia Drug Price by Type (2021-2026) & (USD/Pcs)
Table 48. Global Androgenic Alopecia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 49. Global Androgenic Alopecia Drug Sales by Application (2021-2026) & (K Pcs)
Table 50. Global Androgenic Alopecia Drug Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Androgenic Alopecia Drug Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Androgenic Alopecia Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 53. Global Androgenic Alopecia Drug Price by Application (2021-2026) & (USD/Pcs)
Table 54. North America Androgenic Alopecia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 55. North America Androgenic Alopecia Drug Sales by Country (2021-2026) & (K Pcs)
Table 56. North America Androgenic Alopecia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Androgenic Alopecia Drug Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Androgenic Alopecia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 59. North America Androgenic Alopecia Drug Sales by Type (2021-2026) & (K Pcs)
Table 60. North America Androgenic Alopecia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 61. North America Androgenic Alopecia Drug Sales by Application (2021-2026) & (K Pcs)
Table 62. Europe Androgenic Alopecia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 63. Europe Androgenic Alopecia Drug Sales by Country (2021-2026) & (K Pcs)
Table 64. Europe Androgenic Alopecia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Androgenic Alopecia Drug Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Androgenic Alopecia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 67. Europe Androgenic Alopecia Drug Sales by Type (2021-2026) & (K Pcs)
Table 68. Europe Androgenic Alopecia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 69. Europe Androgenic Alopecia Drug Sales by Application (2021-2026) & (K Pcs)
Table 70. Asia-Pacific Androgenic Alopecia Drug Sales by Region (2016-2021e) & (K Pcs)
Table 71. Asia-Pacific Androgenic Alopecia Drug Sales by Region (2021-2026) & (K Pcs)
Table 72. Asia-Pacific Androgenic Alopecia Drug Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Androgenic Alopecia Drug Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Androgenic Alopecia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 75. Asia-Pacific Androgenic Alopecia Drug Sales by Type (2021-2026) & (K Pcs)
Table 76. Asia-Pacific Androgenic Alopecia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 77. Asia-Pacific Androgenic Alopecia Drug Sales by Application (2021-2026) & (K Pcs)
Table 78. South America Androgenic Alopecia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 79. South America Androgenic Alopecia Drug Sales by Country (2021-2026) & (K Pcs)
Table 80. South America Androgenic Alopecia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Androgenic Alopecia Drug Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Androgenic Alopecia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 83. South America Androgenic Alopecia Drug Sales by Type (2021-2026) & (K Pcs)
Table 84. South America Androgenic Alopecia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 85. South America Androgenic Alopecia Drug Sales by Application (2021-2026) & (K Pcs)
Table 86. Middle East & Africa Androgenic Alopecia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 87. Middle East & Africa Androgenic Alopecia Drug Sales by Country (2021-2026) & (K Pcs)
Table 88. Middle East & Africa Androgenic Alopecia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Androgenic Alopecia Drug Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Androgenic Alopecia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 91. Middle East & Africa Androgenic Alopecia Drug Sales by Type (2021-2026) & (K Pcs)
Table 92. Middle East & Africa Androgenic Alopecia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 93. Middle East & Africa Androgenic Alopecia Drug Sales by Application (2021-2026) & (K Pcs)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Androgenic Alopecia Drug Typical Distributors
Table 97. Androgenic Alopecia Drug Typical Customers
List of Figures
Figure 1. Androgenic Alopecia Drug Picture
Figure 2. Global Androgenic Alopecia Drug Sales Market Share by Type in 2020
Figure 3. RK-023
Figure 4. Refagro
Figure 5. RCH-01
Figure 6. SM-04554
Figure 7. HYG-440
Figure 8. Others
Figure 9. Global Androgenic Alopecia Drug Sales Market Share by Application in 2020
Figure 10. Clinic
Figure 11. Hospital
Figure 12. Home Use
Figure 13. Global Androgenic Alopecia Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Androgenic Alopecia Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Androgenic Alopecia Drug Sales (2016-2026) & (K Pcs)
Figure 16. Global Androgenic Alopecia Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 17. Global Androgenic Alopecia Drug Production Capacity (2016-2026) & (K Pcs)
Figure 18. Global Androgenic Alopecia Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Androgenic Alopecia Drug Market Drivers
Figure 20. Androgenic Alopecia Drug Market Restraints
Figure 21. Androgenic Alopecia Drug Market Trends
Figure 22. Global Androgenic Alopecia Drug Sales Market Share by Manufacturer in 2020
Figure 23. Global Androgenic Alopecia Drug Revenue Market Share by Manufacturer in 2020
Figure 24. Androgenic Alopecia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Androgenic Alopecia Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Androgenic Alopecia Drug Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Androgenic Alopecia Drug Sales Market Share by Region (2016-2026)
Figure 28. Global Androgenic Alopecia Drug Revenue Market Share by Region (2016-2026)
Figure 29. North America Androgenic Alopecia Drug Revenue (2016-2026) & (USD Million)
Figure 30. Europe Androgenic Alopecia Drug Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Androgenic Alopecia Drug Revenue (2016-2026) & (USD Million)
Figure 32. South America Androgenic Alopecia Drug Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Androgenic Alopecia Drug Revenue (2016-2026) & (USD Million)
Figure 34. Global Androgenic Alopecia Drug Sales Market Share by Type (2016-2026)
Figure 35. Global Androgenic Alopecia Drug Revenue Market Share by Type (2016-2026)
Figure 36. Global Androgenic Alopecia Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 37. Global Androgenic Alopecia Drug Sales Market Share by Application (2016-2026)
Figure 38. Global Androgenic Alopecia Drug Revenue Market Share by Application (2016-2026)
Figure 39. Global Androgenic Alopecia Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 40. North America Androgenic Alopecia Drug Sales Market Share by Type (2016-2026)
Figure 41. North America Androgenic Alopecia Drug Sales Market Share by Application (2016-2026)
Figure 42. North America Androgenic Alopecia Drug Sales Market Share by Country (2016-2026)
Figure 43. North America Androgenic Alopecia Drug Revenue Market Share by Country (2016-2026)
Figure 44. United States Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Androgenic Alopecia Drug Sales Market Share by Type (2016-2026)
Figure 48. Europe Androgenic Alopecia Drug Sales Market Share by Application (2016-2026)
Figure 49. Europe Androgenic Alopecia Drug Sales Market Share by Country (2016-2026)
Figure 50. Europe Androgenic Alopecia Drug Revenue Market Share by Country (2016-2026)
Figure 51. Germany Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Androgenic Alopecia Drug Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Androgenic Alopecia Drug Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Androgenic Alopecia Drug Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Androgenic Alopecia Drug Revenue Market Share by Region (2016-2026)
Figure 60. China Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Androgenic Alopecia Drug Sales Market Share by Type (2016-2026)
Figure 67. South America Androgenic Alopecia Drug Sales Market Share by Application (2016-2026)
Figure 68. South America Androgenic Alopecia Drug Sales Market Share by Country (2016-2026)
Figure 69. South America Androgenic Alopecia Drug Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Androgenic Alopecia Drug Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Androgenic Alopecia Drug Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Androgenic Alopecia Drug Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Androgenic Alopecia Drug Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Androgenic Alopecia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のスニチニブ薬市場 2021：企業別、地域別、種類・用途別 The Sunitinib Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…- 世界のNSCLC用標的薬物MEK阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug MEK Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界のアンブリセンタン薬市場 2021：企業別、地域別、種類・用途別 The Ambrisentan Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界のドルテグラビル/リルピビリン併用薬市場 2021：企業別、地域別、種類・用途別 The Dolutegravir/Rilpivirine Combination Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界のコクシジオイデス症治療薬市場 2021：企業別、地域別、種類・用途別 The Coccidioidomycosis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…